Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 2/20 | 0.72 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.60 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.60 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.60 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.60 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.60 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3675463 | 0.89 | KCNK3 (0.84) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL31242942 | 0.88 | KDM4E (0.63) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL316626 | 0.88 | KDM4E (0.63) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| Hydrochloric Acid SCHEMBL15137104 | 0.87 | KDM4E (0.61) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL2107465 | 0.86 | KCNK3 (0.74) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL1811760 | 0.86 | KCNK3 (0.79) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| Hydrochloric Acid SCHEMBL2107467 | 0.84 | KCNK3 (0.77) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL1455836 | 0.84 | KCNK3 (0.72) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL3786882 | 0.83 | KCNK3 (0.87) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| Cyanide SCHEMBL29178066 | 0.83 | KDM4E (0.58) | KCNK3KCNK9NPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7312181-B2 | Acylated thiosemicarbazides as herbicides | CROPSOLUTION, INC. (US) | 2007-12-25 | — | — | US | disclosed |
| WO-2006110276-A2 | ACYLATED THIOSEMICARBAZIDES AS HERBICIDES | CROPSOLUTION, INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| US-20060229206-A1 | Acylated thiosemicarbazides as herbicides | ATP CAPITAL LP | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060229206-A1 | Acylated thiosemicarbazides as herbicides | NAT1, AADAC, HACL2 | KCNK3 906/4885KCNK9 1577/4885NPC1 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.